Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07642531 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Modular Cloud Platform For Fertility Preservation

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-02
View on ClinicalTrials.gov ↗

Amendment history

2026-06-11
minor
Study Status, Study Description, Study Design, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v1
Eligibility criteria+7 characters
[...] e (e.g., stroke, multiple sclerosis) or cognitive impairment, Advanced-stage gynecologic cancers, Failure to complete the follow-up period, Initiation of oncologic treatment during the study period, Non-completion or incomplete completion of the data collection instruments, Non-use of the platform among participants allocated to the intervention group, History of prior cancer treatment.
Study sitesdetails revised at 1 of 1 site
2026-06-08
minor
Original filing
The research was designed as a randomized controlled study to determine the effectiveness of a modular cloud-based training platform in increasing awareness of fertility preservation. The study aims to develop a free, modular, cloud-based, sustainable digital platform to increase fertility awareness. The platform will provide basic information on fertility preservation methods in plain language to support informed decisions. Content will be based on European Society of Human Reproduction and Embryology (ESHRE) , International Federation of Gynaecology and Obstetrics (FIGO) and Asian Society of Gynecologic Oncology (ASCO) guidelines. The study targets not only cancer patients but also women requesting fertility preservation for medical or social reasons. In the first stage, the platform will be designed with the ADDIE instructional design model (Analysis, Design, Development, Implementation, Evaluation) and content created per international guidelines. In the second stage, the prototype will be pilot-tested and revised. In the third stage, effectiveness will be tested through a randomized controlled trial. Educational modules will be provided to the intervention group, while the control group will receive brochures. The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G\*Power, is 140 total (70 per group).
Trial Details
NCT Number NCT07642531
Lead Sponsor Biruni University
Collaborators: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Conditions Fertility Preservation, Gynecologic Cancers
Enrollment 140 participants
Start Date 2026-09-02
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-12